GLP-2 ELISA

$1,155.00
Catalog
48-GP2HU-E01.1

The GLP-2 ELISA is designed for determination of GLP-2 in Plasma and Serum samples. The assay design of the GLP-2 ELISA is based on a competitive enzyme immunoassay format using a highly specific antibody to human GLP-2 and a biotin – avidin affinity system. The GLP-2 ELISA includes all components (96 well Ab coated plate, labeled antigen, substrate, standards and dilution and wash buffer) necessary to complete the GLP-2 ELISA. 

Species
Human
Regulatory Status
Research Use Only. Not for Use in Diagnostic Procedures.
Product Distribution
Available Worldwide
Range
0.412 - 100 ng/mL
Sensitivity
0.412 ng/mL
Sizes
96 Wells
Sample Types
Plasma, Serum
Inc Time Overnight
No
Inc Time See Protocol
No
Sample Size
25
Detection
Colorimetric
The GLP-2 ELISA is based on a competitive enzyme immunoassay using a combination of highly specific antibody to human GLP-2 and the biotin-avidin affinity system. Standards, samples, biotinylated human GLP-2, and rabbit anti-GLP-2 antibody are added to the microplate wells coated in goat anti-rabbit IgG for the competitive immunoreaction. After incubation and plate washing, horse radish peroxidase (HRP)-labeled streptavidin (SA) is added to form an HRP-labeled SA - biotinylated GLP-2 - antibody complex on the surface of the wells. Finally, HRP enzyme activity is determined by o-phenylenediamine dihydrochloride (OPD) and the concentration of human GLP-2 is calculated. The proglucagon gene is expressed in both pancreatic A cells and intestinal L cells. Tissue-specific posttranslational processing of proglucagon by prohormone convertase produces different proglucagon derived peptides (PGDPs) in both the pancreas and intestine. The most notable pancreatic PGDP is glucagon, whereas intestinal L cells produce several structurally related peptides, including glucagon-like peptide 1 (GLP-1) and 2 (GLP-2), as well as glicentin and oxyntomodulin which contain the glucagon sequence in their molecules. Among PGDPs, GLP-2 has been found to result in intestinal epithelial proliferation.

GLP-2 ELISA

48-GP2HU-E01.1

Billing Address

Shipping Address

Resources to advance your discoveries 

Recent posts

8 Questions to Ask Before Choosing an Allergy Testing Platform
8 Questions to Ask Before Choosing an Allergy Testing Platform
1. What percentage of your IgE allergy testing panel consists of molecular allergens rather than allergen extracts? The ALEX2 IgE allergen panel consists of 117 extracts and 183 molecular allergens. This represents the largest panel of molecular allergens on the market, including 50 unique...
View Now
Understanding IgE Allergy Test Results
Understanding IgE Allergy Test Results
Cases of food and environmental allergies have been increasing over the last decade. While conservative estimates suggest IgE-mediated allergy affects 6-8% of children and 2-3% of adults, some estimates are as high as 30%.3, 2 Symptoms can range from mild to severe and include itching, hives,...
View Now
Improving Food Elimination Diets with IgG Testing
Improving Food Elimination Diets with IgG Testing
Food sensitivity or food intolerance involves a non-allergic response to a food or food additive. In a recent on-line survey conducted in the U.S., 24% of adults aged 18 to 79 reported a food intolerance. While a food allergy is typically mediated by IgE antibodies, adverse reactions to food...
View Now

Recent posts

 ALPCO Glucagon ELISA
Spotlight: ALPCO Glucagon ELISA
The ALPCO Glucagon ELISA is for the quantitative determination of glucagon in human EDTA plasma. This assay was developed for ease-of-use and demonstrates superior sensitivity while eliminating cross-reactivity issues present in other commercially-available assays. 
View Now
Accuracy in Calprotectin Testing
Accuracy in Calprotectin Testing
ALPCO’s automated turbidimetric solution for calprotectin testing offers enhanced efficiency without compromising clinical sensitivity or specificity. Clinicians can prioritize endoscopic evaluation for the patients that need it most and quickly put IBS patients on the right treatment path. 
View Now
Clinical Lab on Fecal Calprotectin Testing
Webinar On-Demand: A Clinical Laboratory’s Perspective on Fecal Calprotectin Testing
Join our speaker from Department of Pathology , University of Utah School of Medicine, Dr. Heather Nelson, to discuss how to validate and launch a FDA-approved assay.
View Now

Biomarkers of Energy Homeostasis Brochure

Energy homeostasis is a focus of research into diabetes and obesity. Read about how our assays in this area can assist both academic and industry researchers.

Complement System Solutions for Drug Development and Clinical Research Datasheet

The complement system is essential to innate immunity from a variety of diseases. ALPCO’s full range of complement system immunoassays can drive discovery.

Melatonin Products for Sleep Disorder-Related Research Datasheet

The melatonin hormone affects the circadian rhythm and sleep-wake cycle. Find out about our immunoassays and products that explore melatonin and sleep disorders.